DIABETES IN POLAND: EPIDEMIOLOGY, MORTALITY AND DIAGNOSTICS

Illia Koval; Klaudia Romejko; Barbara Kujawa; Sandra Sienkiewicz; Jagoda Saniuk; Justyna Rajczyk; Aleksandra Oparcik; Kacper Wojtala; Weronika Kielińska; Małgorzata Golik; Anna Popowicz; Michał Dorota; Dominik Szklarkowski; Gracjan Kosiorowski

doi:10.31435/ijitss.4(48).2025.4361

Illia Koval Medicine, Provincial Hospital in Poznań, Poznań, Poland https://orcid.org/0009-0002-1109-6354
Klaudia Romejko Medicine, Provincial Hospital in Poznań, Poznań, Poland https://orcid.org/0009-0003-6452-1323
Barbara Kujawa Medicine, Provincial Hospital in Poznań, Poznań, Poland https://orcid.org/0009-0000-3951-965X
Sandra Sienkiewicz Medicine, Provincial Hospital in Poznań, Poznań, Poland https://orcid.org/0000-0002-4454-9498
Jagoda Saniuk Medicine, Provincial Hospital in Poznań, Poznań, Poland https://orcid.org/0009-0006-3193-8634
Justyna Rajczyk Medicine, Provincial Hospital in Poznań, Poznań, Poland https://orcid.org/0009-0003-1307-931X
Aleksandra Oparcik Medicine, Centrum Medyczne HCP, Poznań, Poland https://orcid.org/0009-0008-0438-3797
Kacper Wojtala Medical Center HCP, Poznań, Poland https://orcid.org/0009-0009-8100-8074
Weronika Kielińska Medicine, Provincial Hospital in Poznań, Poznań, Poland https://orcid.org/0009-0006-4901-0332
Małgorzata Golik Zaglebie Oncology Center – Specialist Hospital named after Sz. Starkiewicz, Dąbrowa Górnicza, Poland https://orcid.org/0009-0004-6040-5744
Anna Popowicz Zaglebie Oncology Center – Specialist Hospital named after Sz. Starkiewicz, Dąbrowa Górnicza, Poland https://orcid.org/0009-0004-6114-307X
Michał Dorota Central Clinical Hospital of Medical University of Lodz, Lodz, Poland https://orcid.org/0009-0008-7481-0045
Dominik Szklarkowski Poznan University of Medical Sciences, Collegium Maius, Poznań, Poland https://orcid.org/0009-0002-9180-9958
Gracjan Kosiorowski JCM Jawor, Jawor, Poland https://orcid.org/0009-0008-9299-1644

DOI: https://doi.org/10.31435/ijitss.4(48).2025.4361

Keywords: Diabetes Mellitus, Type 1 Diabetes, Type 2 Diabetes, Insulin Resistance, Diabetic Complications, Epidemiology In Poland

Abstract

This paper presents current knowledge on diabetes mellitus (ICD-10 E10-E14) and its clinical impact. Diabetes is a growing global problem, with over 3 million adults affected in Poland alone. The disease develops as type 1, caused by autoimmune destruction of pancreatic β-cells, or as type 2, driven mainly by insulin resistance and obesity. Both forms lead to impaired glucose uptake and abnormal fat and protein metabolism. Common symptoms include thirst, polyuria, fatigue, weight loss, and recurrent infections, though type 2 diabetes often remains silent for years. Persistent hyperglycemia promotes toxic metabolite accumulation, microangiopathy, neuropathy, and multiorgan complications. Cardiovascular manifestations, such as diabetic cardiomyopathy and arrhythmias, significantly increase morbidity and mortality. Early detection, lifestyle modification, and improved diagnostic strategies remain essential to reduce the burden of disease.

References

International Diabetes Federation. IDF Diabetes Atlas, 11th ed. 2024/2025. Country Profile: Poland.. (2024/2025). https://diabetesatlas.org/media/uploads/sites/3/2025/04/IDF_Atlas_11th_Edition_2025.pdf.

Statistics Poland. SDG Indicators (including 3.1.e, 3.4.1) Updates 2023-2025. Warsaw. (2023-2025). Accessed: 12.09.2025: https://sdg.gov.pl/.

Polish Diabetes Association. Clinical Guidelines 2024/2025. (2025). Accessed: 12.09.2025: https://ptdiab.pl/zalecenia-ptd/zalecenia-kliniczne-dotyczace-postepowania-u-osob-z-cukrzyca-2025.

American Diabetes Association Professional Practice Committee. : 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025. . Diabetes Care. 2025, 48(1 Suppl 1):181-206. 10.2337/dc25-S009

Davies MJ, Aroda VR, Collins BS, et al.: Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).. Diabetes Care. 2022, 45(11):2753-2786. 10.2337/dci22-0034.

Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group.: KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.. Kidney Int. 2022, 102(5S):1-127. 10.1016/j.kint.2022.06.008.

Cosentino F, Grant PJ, Aboyans V, et al.: 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). European Heart Journal. 2020, 41(2):255-323. 10.1093/eurheartj/ehz486

Pikala M, Burzyńska M: Mortality and Years of Life Lost from Diabetes Mellitus in Poland: A Register-Based Study (2000-2022). Nutrients. 2024, 16(21):3597. 10.3390/nu16213597

Agencja Oceny Technologii Medycznych i Taryfikacji (AOTMiT).: Recommendation No. 7/2024 of 11 December 2024 of the President of AOTMiT concerning recommended medical technologies, actions within health policy programs and conditions of implementation of these programs, regarding primary prevention of type 2 diabetes. Warsaw: AOTMiT. 2024,

National Institute of Public Health - National Research Institute (NIZP PZH-PIB). The health situation of the Polish population and its determinants 2023.. (2023). Accessed: 12.09.2025: https://www.pzh.gov.pl/raport-sytuacja-zdrowotna-ludnosci-polski-i-jej-uwarunkowania/.

Ministry of Health of the Republic of Poland. Health Needs Maps 2022-2026. . (2021). Accessed: 12.09.2025: https://basiw.mz.gov.pl/mapy-informacje/mapa-2022-2026/.

National Health Fund. NFZ on health. Diabetes. Report 2019 (data 2013-2018). (2019). Accessed: 12.09.2025: https://ezdrowie.gov.pl/portal/home/badania-i-dane/zdrowe-dane/raporty/nfz-o-zdrowiu-cukrzyca.

DIABETES IN POLAND: EPIDEMIOLOGY, MORTALITY AND DIAGNOSTICS

Abstract

References

Most read articles by the same author(s)